Publications by authors named "Eva Dahlen"

Claim this Profile
B
Bispecific antibodies in cancer immunotherapy.
Eva Dahlén, Niina Veitonmäki, Per Norlén

Ther Adv Vaccines Immunother· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The human agonistic CD40 antibody ADC-1013 eradicates bladder tumors and generates T-cell-dependent tumor immunity.
Sara M Mangsbo, Sissela Broos, Erika Fletcher, Niina Veitonmäki, Christina Furebring

Clin Cancer Res· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of interleukin-1 receptor antagonist mutants with enhanced antagonistic activity in vitro and improved therapeutic efficacy in collagen-induced arthritis.
Eva Dahlén, Karin Barchan, Daniel Herrlander, Patrik Höjman, Marie Karlsson

J Immunotoxicol· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Linomide inhibits insulitis and modulates cytokine production in pancreatic islets in the nonobese diabetic mouse.
Eva Dahlén, Kim Dawe, Lennart Ohlsson, Håkan Hall, Karin Hedse

Int Immunopharmacol· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis